In HEKmTRPM3 cells stimulated with pregnenolone sulfate, Primidone was the most potent TRPM3-inhibiting drug compared with activation without an inhibitor (DMSO control), with an IC50 of 0.6 ± 0.15 μM. In HEK293 cells expressing hTRPM3α2-V992M, Primidone decreased basal calcium levels in a concentration-dependent manner, with an IC50 of 2.41 ± 0.74 μM for V992M. Primidone also efficiently inhibited intrinsic kinase activity in a recombinant human active RIPK1 assay using vehicle alone as the control. [1,2,3]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Inhibition of PregS-Induced Calcium Signaling
Cell-based study · HEKmTRPM3 cells; n = 8 [1]
HEKmTRPM3 cells were incubated with various concentrations of Primidone and assessed for PregS-induced Ca2+ signaling against activation without an inhibitor (DMSO control). Primidone was the most potent TRPM3-inhibiting drug, with an IC50 of 0.6 ± 0.15 μM.
Literature-Reported Treatment Conditions
- Treatment concentration
- various concentrations
- Method
- incubating HEKmTRPM3 cells with various concentrations of the respective drug
- Vehicle
- dimethyl sulfoxide (DMSO)
- Co-treatment
- Other interventions in this design: Pregnenolone sulfate 35 μM. Compound effect isolated by the comparison: Activation without an inhibitor (DMSO control).
- Reported limits
- Not stated in the sentences used: schedule.
Methods and source locations
Compound reported in the paper: Primidone
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
2. Materials and methods > 2.1. Stock solutions and drugs (S1, S4); 2. Materials and methods > 2.3. Intracellular Ca2+ analysis in cell suspensions (S12, S14); 3. Results > 3.2. Concentration dependence of drug-induced inhibition of TRPM3-dependent Ca2+ entry and ionic currents (S75, S79); Figure 2. legend (S147, S148)
PregS-induced Ca2+ signal: PregS-induced Ca2+ signal; comparator: Activation without an inhibitor (DMSO control) — 3. Results > 3.2. Concentration dependence of drug-induced inhibition of TRPM3-dependent Ca2+ entry and ionic currents (S75, S79)
Concentration-dependent reduction of basal calcium levels
Cell-based study · HEK293 cells; hTRPM3α2-V992M [2]
HEK293 cells expressing hTRPM3α2-V992M received Primidone by rapid well injection. Primidone decreased basal calcium levels in a concentration-dependent manner, with an IC50 of 2.41 ± 0.74 μM for V992M.
Literature-Reported Treatment Conditions
- Method
- rapid well injection
- Reported limits
- Not stated in the sentences used: dose, schedule, vehicle, control.
Methods and source locations
Compound reported in the paper: Primidone
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results (S12); Materials and methods > Intracellular Ca2+ assay in 96-well plates (S51); Figure 1. legend (S103, S117, S118, S121); Key resources table (T1.r2)
basal Ca2+ levels: basal Ca2+ levels — Results (S12); Figure 1. legend (S118, S121)
Inhibition of recombinant kinase activity
Biochemical assay · Recombinant human active RIPK1 (aa 1-327) [3]
Recombinant human active RIPK1 was pre-incubated with Primidone at 1 mM for 15 min, with vehicle alone as the control. Intrinsic RIPK1 kinase activity during the reaction phase was efficiently inhibited in the presence of Primidone.
Literature-Reported Treatment Conditions
- Treatment concentration
- 1 mM
- Exposure duration
- for 15 min
- Method
- pre-incubated
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Primidone
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and methods > Kinase activity assay (S46, S48); Results > Primidone is an effective inhibitor of RIPK1 (S187)
RIPK1 kinase activity: RIPK1 kinase activity; comparator: vehicle alone — Materials and methods > Kinase activity assay (S48); Results > Primidone is an effective inhibitor of RIPK1 (S187)